NVSTEnvista Holdings Corp
- Market cap
- $3.79B
- as of 2026-10-23
- Latest close
- $23.60
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Medical Instruments & Supplies
- as of 2026-10-24
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2023-11-07
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Hammes Eric D.Chief Financial Officer | Aug 25 | Aug 27 | F | 10,885 | $27.47 | $299,011 | 99,913 | No | Form 4 |
| Befidi RobertPresident, Diagnostics | Aug 25 | Aug 27 | F | 5,147 | $27.47 | $141,388 | 45,785 | No | Form 4 |
| Nilsson StefanPresident, Nobel Biocare | Aug 25 | Aug 27 | F | 804 | $27.47 | $22,086 | 61,560 | No | Form 4 |
| Acurio VeronicaPresident, Orthodontics | Aug 25 | Aug 27 | F | 7,710 | $27.47 | $211,794 | 48,806 | No | Form 4 |
| Reis MischaSVP, Strategy & Bus. Dev. | Aug 20 | Aug 24 | S | 8,000 | $27.50 | Sale −$220,000 | 27,321 | Yes | Form 4 |
| Hammes Eric D.Chief Financial Officer | Aug 18 | Aug 20 | A · derivative | 47,970 | $0.00 | $0 | 47,970 | No | Form 4 |
| Keel Paul AChief Executive Officer | Aug 18 | Aug 20 | A | 179,730 | $0.00 | $0 | 551,304 | No | Form 4 |
| Keel Paul AChief Executive Officer | Aug 18 | Aug 20 | A · derivative | 159,900 | $0.00 | $0 | 159,900 | No | Form 4 |
| Keel Paul AChief Executive Officer | May 25 | May 27 | F | 12,811 | $23.43 | $300,162 | 371,574 | No | Form 4 |
| Tsingos Christine A | May 19 | May 21 | A | 9,330 | $0.00 | $0 | 59,930 | No | Form 4 |
| Raskas Daniel | May 19 | May 21 | A | 9,330 | $0.00 | $0 | 54,010 | No | Form 4 |
| Gallahue Kieran | May 19 | May 21 | A | 9,330 | $0.00 | $0 | 54,010 | No | Form 4 |
| Huennekens R Scott | May 19 | May 21 | A | 12,585 | $0.00 | $0 | 82,105 | No | Form 4 |
| Jain Vivek | May 19 | May 21 | A | 9,330 | $0.00 | $0 | 52,945 | No | Form 4 |
| Carruthers Wendy | May 19 | May 21 | A | 9,330 | $0.00 | $0 | 59,940 | No | Form 4 |
| Pierce James Andrew | May 19 | May 21 | A | 9,330 | $0.00 | $0 | 18,485 | No | Form 4 |
| Hammes Eric D.Chief Financial Officer | Feb 25 | Feb 27 | F | 2,045 | $29.59 | $60,512 | 94,743 | No | Form 4 |
| Hammes Eric D.Chief Financial Officer | Feb 25 | Feb 27 | A | 16,055 | $0.00 | $0 | 110,798 | No | Form 4 |
| Hammes Eric D.Chief Financial Officer | Feb 25 | Feb 27 | A · derivative | 29,225 | $0.00 | $0 | 29,225 | No | Form 4 |
| Hammes Eric D.Chief Financial Officer | Feb 25 | Feb 27 | A · derivative | 38,040 | $29.59 | $1,125,604 | 38,040 | No | Form 4 |
| Keel Paul AChief Executive Officer | Feb 25 | Feb 27 | F | 11,840 | $29.59 | $350,346 | 335,715 | No | Form 4 |
| Keel Paul AChief Executive Officer | Feb 25 | Feb 27 | A | 48,670 | $0.00 | $0 | 384,385 | No | Form 4 |
| Keel Paul AChief Executive Officer | Feb 25 | Feb 27 | A · derivative | 132,885 | $0.00 | $0 | 132,885 | No | Form 4 |
| Keel Paul AChief Executive Officer | Feb 25 | Feb 27 | A · derivative | 115,320 | $29.59 | $3,412,319 | 115,320 | No | Form 4 |
| Nance Mark EGeneral Counsel | Feb 25 | Feb 27 | F | 3,368 | $29.59 | $99,659 | 68,577 | No | Form 4 |
| Nance Mark EGeneral Counsel | Feb 25 | Feb 27 | A | 12,675 | $0.00 | $0 | 81,252 | No | Form 4 |
| Nance Mark EGeneral Counsel | Feb 25 | Feb 27 | A · derivative | 23,070 | $0.00 | $0 | 23,070 | No | Form 4 |
| Nance Mark EGeneral Counsel | Feb 25 | Feb 27 | A · derivative | 30,040 | $29.59 | $888,884 | 30,040 | No | Form 4 |
| Reis MischaSVP, Strategy & Bus. Dev. | Feb 25 | Feb 27 | F | 2,976 | $29.59 | $88,060 | 29,406 | No | Form 4 |
| Reis MischaSVP, Strategy & Bus. Dev. | Feb 25 | Feb 27 | A | 5,915 | $0.00 | $0 | 35,321 | No | Form 4 |
| Reis MischaSVP, Strategy & Bus. Dev. | Feb 25 | Feb 27 | A · derivative | 10,770 | $0.00 | $0 | 10,770 | No | Form 4 |
| Reis MischaSVP, Strategy & Bus. Dev. | Feb 25 | Feb 27 | A · derivative | 14,020 | $29.59 | $414,852 | 14,020 | No | Form 4 |
| Kaabi Faez CChief Accounting Officer | Feb 25 | Feb 27 | F | 4,964 | $29.59 | $146,885 | 45,032 | No | Form 4 |
| Kaabi Faez CChief Accounting Officer | Feb 25 | Feb 27 | A | 13,520 | $0.00 | $0 | 58,552 | No | Form 4 |
| Befidi RobertPresident, Diagnostics | Feb 25 | Feb 27 | F | 2,177 | $29.59 | $64,417 | 43,327 | No | Form 4 |
| Befidi RobertPresident, Diagnostics | Feb 25 | Feb 27 | A | 7,605 | $0.00 | $0 | 50,932 | No | Form 4 |
| Befidi RobertPresident, Diagnostics | Feb 25 | Feb 27 | A · derivative | 13,845 | $0.00 | $0 | 13,845 | No | Form 4 |
| Befidi RobertPresident, Diagnostics | Feb 25 | Feb 27 | A · derivative | 18,020 | $29.59 | $533,212 | 18,020 | No | Form 4 |
| Nilsson StefanPresident, Nobel Biocare | Feb 25 | Feb 27 | F | 182 | $29.59 | $5,385 | 54,759 | No | Form 4 |
| Nilsson StefanPresident, Nobel Biocare | Feb 25 | Feb 27 | A | 7,605 | $0.00 | $0 | 62,364 | No | Form 4 |
| Nilsson StefanPresident, Nobel Biocare | Feb 25 | Feb 27 | A · derivative | 13,845 | $0.00 | $0 | 13,845 | No | Form 4 |
| Nilsson StefanPresident, Nobel Biocare | Feb 25 | Feb 27 | A · derivative | 18,020 | $29.59 | $533,212 | 18,020 | No | Form 4 |
| Acurio VeronicaPresident, Orthodontics | Feb 25 | Feb 27 | F | 1,412 | $29.59 | $41,781 | 48,911 | No | Form 4 |
| Acurio VeronicaPresident, Orthodontics | Feb 25 | Feb 27 | A | 7,605 | $0.00 | $0 | 56,516 | No | Form 4 |
| Acurio VeronicaPresident, Orthodontics | Feb 25 | Feb 27 | A · derivative | 13,845 | $0.00 | $0 | 13,845 | No | Form 4 |
| Acurio VeronicaPresident, Orthodontics | Feb 25 | Feb 27 | A · derivative | 18,020 | $29.59 | $533,212 | 18,020 | No | Form 4 |
| Reis MischaSVP, Strategy & Bus. Dev. | Feb 10 | Feb 11 | M | 4,041 | $19.04 | $76,941 | 36,423 | Yes | Form 4 |
| Reis MischaSVP, Strategy & Bus. Dev. | Feb 10 | Feb 11 | S | 4,041 | $30.00 | Sale −$121,230 | 32,382 | Yes | Form 4 |
| Reis MischaSVP, Strategy & Bus. Dev. | Feb 10 | Feb 11 | M | 5,634 | $15.97 | $89,975 | 38,016 | Yes | Form 4 |
| Reis MischaSVP, Strategy & Bus. Dev. | Feb 10 | Feb 11 | S | 5,634 | $30.00 | Sale −$169,020 | 32,382 | Yes | Form 4 |
| Reis MischaSVP, Strategy & Bus. Dev. | Feb 10 | Feb 11 | M · derivative | 4,041 | $19.04 | $76,941 | not reported | Yes | Form 4 |
| Reis MischaSVP, Strategy & Bus. Dev. | Feb 10 | Feb 11 | M · derivative | 5,634 | $15.97 | $89,975 | not reported | Yes | Form 4 |
| Hammes Eric D.Chief Financial Officer | Feb 1 | Feb 3 | A · derivative | 1,119 | $23.47 | $26,263 | 1,119 | No | Form 4 |
| Keel Paul AChief Executive Officer | Feb 1 | Feb 3 | A · derivative | 4,091 | $23.47 | $96,016 | 4,091 | No | Form 4 |
| Nance Mark EGeneral Counsel | Feb 1 | Feb 3 | A · derivative | 2,006 | $23.47 | $47,081 | 7,587 | No | Form 4 |
| Reis MischaSVP, Strategy & Bus. Dev. | Feb 1 | Feb 3 | A · derivative | 2,919 | $21.71 | $63,371 | 29,357 | No | Form 4 |
| Kaabi Faez CChief Accounting Officer | Feb 1 | Feb 3 | A · derivative | 1,186 | $23.47 | $27,835 | 5,040 | No | Form 4 |
| Befidi RobertPresident, Diagnostics | Feb 1 | Feb 3 | A · derivative | 998 | $23.47 | $23,423 | 2,149 | No | Form 4 |
| Acurio VeronicaPresident, Orthodontics | Feb 1 | Feb 3 | A · derivative | 998 | $23.47 | $23,423 | 998 | No | Form 4 |
| Keel Paul AChief Executive Officer | Nov 1, 2025 | Nov 4, 2025 | F | 54,097 | $20.35 | $1,100,874 | 347,555 | No | Form 4 |
| Hammes Eric D.Chief Financial Officer | Aug 25, 2025 | Aug 27, 2025 | F | 7,654 | $21.12 | $161,652 | 96,788 | No | Form 4 |
| Reis MischaSVP, Strategy & Bus. Dev. | Aug 25, 2025 | Aug 27, 2025 | S | 15,000 | $21.60 | Sale −$324,000 | 32,382 | Yes | Form 4 |
| Befidi RobertPresident, Diagnostics | Aug 25, 2025 | Aug 27, 2025 | F | 3,454 | $21.12 | $72,948 | 45,504 | No | Form 4 |
| Nilsson StefanPresident, Nobel Biocare | Aug 25, 2025 | Aug 27, 2025 | F | 804 | $21.12 | $16,980 | 54,941 | No | Form 4 |
| Acurio VeronicaPresident, Orthodontics | Aug 25, 2025 | Aug 27, 2025 | F | 5,422 | $21.12 | $114,513 | 50,323 | No | Form 4 |
| Pierce James Andrew | Jul 14, 2025 | Jul 16, 2025 | A | 9,155 | $0.00 | $0 | 9,155 | No | Form 4 |
| Huennekens R Scott | Jun 10, 2025 | Jun 12, 2025 | A | 14,370 | $0.00 | $0 | 69,520 | No | Form 4 |
| Hulit Barbara B. | Jun 10, 2025 | Jun 12, 2025 | A | 10,450 | $0.00 | $0 | 79,820 | No | Form 4 |
| Tsingos Christine A | Jun 10, 2025 | Jun 12, 2025 | A | 10,450 | $0.00 | $0 | 50,600 | No | Form 4 |
| Carruthers Wendy | Jun 10, 2025 | Jun 12, 2025 | A | 10,450 | $0.00 | $0 | 50,610 | No | Form 4 |
| Jain Vivek | Jun 10, 2025 | Jun 12, 2025 | A | 10,450 | $0.00 | $0 | 43,615 | No | Form 4 |
| Raskas Daniel | Jun 10, 2025 | Jun 12, 2025 | A | 10,450 | $0.00 | $0 | 44,680 | No | Form 4 |
| Gallahue Kieran | Jun 10, 2025 | Jun 12, 2025 | A | 10,450 | $0.00 | $0 | 44,680 | No | Form 4 |
| Keel Paul AChief Executive Officer | May 25, 2025 | May 27, 2025 | F | 12,787 | $16.72 | $213,799 | 401,652 | No | Form 4 |
| Reis MischaSVP, Strategy & Bus. Dev. | Feb 26, 2025 | Feb 27, 2025 | A | 8,475 | $0.00 | $0 | 47,382 | No | Form 4 |
| Nance Mark EGeneral Counsel | Feb 25, 2025 | Feb 27, 2025 | F | 3,691 | $20.66 | $76,256 | 53,790 | No | Form 4 |
| Nance Mark EGeneral Counsel | Feb 25, 2025 | Feb 27, 2025 | A | 18,155 | $0.00 | $0 | 71,945 | No | Form 4 |
| Nance Mark EGeneral Counsel | Feb 25, 2025 | Feb 27, 2025 | A · derivative | 33,455 | $0.00 | $0 | 33,455 | No | Form 4 |
| Nance Mark EGeneral Counsel | Feb 25, 2025 | Feb 27, 2025 | A · derivative | 42,370 | $20.66 | $875,364 | 42,370 | No | Form 4 |
| Hammes Eric D.Chief Financial Officer | Feb 25, 2025 | Feb 27, 2025 | A | 15,735 | $0.00 | $0 | 104,442 | No | Form 4 |
| Hammes Eric D.Chief Financial Officer | Feb 25, 2025 | Feb 27, 2025 | A · derivative | 28,995 | $0.00 | $0 | 28,995 | No | Form 4 |
| Hammes Eric D.Chief Financial Officer | Feb 25, 2025 | Feb 27, 2025 | A · derivative | 36,720 | $20.66 | $758,635 | 36,720 | No | Form 4 |
| Befidi RobertPresident, Diagnostics | Feb 25, 2025 | Feb 27, 2025 | F | 1,123 | $20.66 | $23,201 | 38,668 | No | Form 4 |
| Befidi RobertPresident, Diagnostics | Feb 25, 2025 | Feb 27, 2025 | A | 10,290 | $0.00 | $0 | 48,958 | No | Form 4 |
| Befidi RobertPresident, Diagnostics | Feb 25, 2025 | Feb 27, 2025 | A · derivative | 18,960 | $0.00 | $0 | 18,960 | No | Form 4 |
| Befidi RobertPresident, Diagnostics | Feb 25, 2025 | Feb 27, 2025 | A · derivative | 24,010 | $20.66 | $496,047 | 24,010 | No | Form 4 |
| Nilsson StefanPresident, Nobel Biocare | Feb 25, 2025 | Feb 27, 2025 | A | 10,290 | $0.00 | $0 | 55,745 | No | Form 4 |
| Nilsson StefanPresident, Nobel Biocare | Feb 25, 2025 | Feb 27, 2025 | A · derivative | 18,960 | $0.00 | $0 | 18,960 | No | Form 4 |
| Nilsson StefanPresident, Nobel Biocare | Feb 25, 2025 | Feb 27, 2025 | A · derivative | 24,010 | $20.66 | $496,047 | 24,010 | No | Form 4 |
| Acurio VeronicaPresident, Orthodontics | Feb 25, 2025 | Feb 27, 2025 | A | 10,290 | $0.00 | $0 | 55,745 | No | Form 4 |
| Acurio VeronicaPresident, Orthodontics | Feb 25, 2025 | Feb 27, 2025 | A · derivative | 18,960 | $0.00 | $0 | 18,960 | No | Form 4 |
| Acurio VeronicaPresident, Orthodontics | Feb 25, 2025 | Feb 27, 2025 | A · derivative | 24,010 | $20.66 | $496,047 | 24,010 | No | Form 4 |
| Keel Paul AChief Executive Officer | Feb 25, 2025 | Feb 27, 2025 | A | 65,830 | $0.00 | $0 | 414,439 | No | Form 4 |
| Keel Paul AChief Executive Officer | Feb 25, 2025 | Feb 27, 2025 | A · derivative | 181,985 | $0.00 | $0 | 181,985 | No | Form 4 |
| Keel Paul AChief Executive Officer | Feb 25, 2025 | Feb 27, 2025 | A · derivative | 153,660 | $20.66 | $3,174,616 | 153,660 | No | Form 4 |
| Reis MischaSVP, Strategy & Bus. Dev. | Feb 25, 2025 | Feb 27, 2025 | F | 3,813 | $20.66 | $78,777 | 38,907 | No | Form 4 |
| Reis MischaSVP, Strategy & Bus. Dev. | Feb 25, 2025 | Feb 27, 2025 | A · derivative | 15,615 | $0.00 | $0 | 15,615 | No | Form 4 |
| Reis MischaSVP, Strategy & Bus. Dev. | Feb 25, 2025 | Feb 27, 2025 | A · derivative | 19,780 | $20.66 | $408,655 | 19,780 | No | Form 4 |
| Kaabi Faez CChief Accounting Officer | Feb 25, 2025 | Feb 27, 2025 | F | 4,319 | $20.66 | $89,231 | 40,311 | No | Form 4 |
| Kaabi Faez CChief Accounting Officer | Feb 25, 2025 | Feb 27, 2025 | A | 9,685 | $0.00 | $0 | 49,996 | No | Form 4 |
| Kaabi Faez CChief Accounting Officer | Feb 25, 2025 | Feb 27, 2025 | A · derivative | 22,600 | $20.66 | $466,916 | 22,600 | No | Form 4 |
| Reis MischaSVP, Strategy & Bus. Dev. | Feb 1, 2025 | Feb 4, 2025 | A · derivative | 3,152 | $20.52 | $64,679 | 26,438 | No | Form 4 |
| Kaabi Faez CChief Accounting Officer | Feb 1, 2025 | Feb 4, 2025 | A · derivative | 689 | $20.52 | $14,138 | 3,854 | No | Form 4 |
| Nance Mark EGeneral Counsel | Feb 1, 2025 | Feb 4, 2025 | A · derivative | 965 | $20.52 | $19,802 | 5,581 | No | Form 4 |
| Befidi RobertPresident, Diagnostics | Feb 1, 2025 | Feb 4, 2025 | A · derivative | 1,151 | $20.52 | $23,619 | 1,151 | No | Form 4 |
| Keel Paul AChief Executive Officer | Nov 1, 2024 | Nov 4, 2024 | F | 53,996 | $20.94 | $1,130,676 | 348,609 | No | Form 4 |
| Reis MischaSVP, Strategy & Bus. Dev. | Sep 17, 2024 | Sep 19, 2024 | F | 812 | $19.00 | $15,428 | 42,720 | No | Form 4 |
| Hammes Eric D.Chief Financial Officer | Aug 25, 2024 | Aug 27, 2024 | A | 64,175 | $0.00 | $0 | 88,707 | No | Form 4 |
| Befidi RobertPresident, Diagnostics | Aug 25, 2024 | Aug 27, 2024 | F | 3,454 | $18.70 | $64,590 | 39,791 | No | Form 4 |
| Befidi RobertPresident, Diagnostics | Aug 25, 2024 | Aug 27, 2024 | A · derivative | 70,400 | $18.70 | $1,316,480 | 70,400 | No | Form 4 |
| Reis MischaSVP, Strategy & Bus. Dev. | Aug 25, 2024 | Aug 27, 2024 | A · derivative | 57,980 | $18.70 | $1,084,226 | 57,980 | No | Form 4 |
| Keel Paul AChief Executive Officer | Aug 25, 2024 | Aug 27, 2024 | A · derivative | 485,680 | $18.70 | $9,082,216 | 485,680 | No | Form 4 |
| Nance Mark EGeneral Counsel | Aug 25, 2024 | Aug 27, 2024 | A · derivative | 95,240 | $18.70 | $1,780,988 | 95,240 | No | Form 4 |
| Keel Paul AChief Executive Officer | Aug 13, 2024 | Aug 14, 2024 | P | 30,000 | $16.87 | Purchase +$506,100 | 402,605 | No | Form 4 |
| Hammes Eric D.Chief Financial Officer | Aug 12, 2024 | Aug 13, 2024 | P | 24,532 | $16.33 | Purchase +$400,608 | 24,532 | No | Form 4 |
| Nance Mark EGeneral Counsel | Jul 15, 2024 | Jul 17, 2024 | F | 491 | $15.94 | $7,827 | 57,481 | No | Form 4 |
| Keller StephenPrincipal Financial Officer | Jun 25, 2024 | Jun 27, 2024 | A | 31,250 | $0.00 | $0 | 53,803 | No | Form 4 |
| Keel Paul AChief Executive Officer | May 25, 2024 | May 29, 2024 | A | 71,235 | $0.00 | $0 | 71,235 | No | Form 4 |
| Keel Paul AChief Executive Officer | May 25, 2024 | May 29, 2024 | A | 301,370 | $0.00 | $0 | 372,605 | No | Form 4 |
| Keel Paul AChief Executive Officer | May 25, 2024 | May 29, 2024 | A · derivative | 696,210 | $18.25 | $12,705,833 | 696,210 | No | Form 4 |
| Keel Paul AChief Executive Officer | May 25, 2024 | May 29, 2024 | A · derivative | 164,560 | $18.25 | $3,003,220 | 164,560 | No | Form 4 |
| Keel Paul AChief Executive Officer | May 25, 2024 | May 29, 2024 | A · derivative | 205,265 | $0.00 | $0 | 205,265 | No | Form 4 |
| Conley EricSVP, Orthodontics | May 25, 2024 | May 29, 2024 | F | 642 | $18.25 | $11,717 | 53,223 | No | Form 4 |
| Tsingos Christine A | May 21, 2024 | May 23, 2024 | A | 10,085 | $0.00 | $0 | 40,150 | No | Form 4 |
| Jain Vivek | May 21, 2024 | May 23, 2024 | A | 10,085 | $0.00 | $0 | 33,165 | No | Form 4 |
| Huennekens R Scott | May 21, 2024 | May 23, 2024 | A | 14,170 | $0.00 | $0 | 55,150 | No | Form 4 |
| Hulit Barbara B. | May 21, 2024 | May 23, 2024 | A | 10,085 | $0.00 | $0 | 69,370 | No | Form 4 |
| Raskas Daniel | May 21, 2024 | May 23, 2024 | A | 10,085 | $0.00 | $0 | 34,230 | No | Form 4 |
| Carruthers Wendy | May 21, 2024 | May 23, 2024 | A | 10,085 | $0.00 | $0 | 40,160 | No | Form 4 |
| Gallahue Kieran | May 21, 2024 | May 23, 2024 | A | 10,085 | $0.00 | $0 | 34,230 | No | Form 4 |
| Hulit Barbara B. | Apr 15, 2024 | Apr 16, 2024 | A | 13,065 | $0.00 | $0 | 59,285 | No | Form 4 |
| Hulit Barbara B. | Mar 15, 2024 | Mar 18, 2024 | A | 11,705 | $0.00 | $0 | 46,220 | No | Form 4 |
| Aghdaei AmirChief Executive Officer | Feb 25, 2024 | Feb 27, 2024 | F | 33,367 | $22.65 | $755,763 | 261,995 | No | Form 4 |
| Aghdaei AmirChief Executive Officer | Feb 25, 2024 | Feb 27, 2024 | A | 48,570 | $0.00 | $0 | 310,565 | No | Form 4 |
| Aghdaei AmirChief Executive Officer | Feb 25, 2024 | Feb 27, 2024 | A · derivative | 133,985 | $0.00 | $0 | 133,985 | No | Form 4 |
| Aghdaei AmirChief Executive Officer | Feb 25, 2024 | Feb 27, 2024 | A · derivative | 113,370 | $22.65 | $2,567,831 | 113,370 | No | Form 4 |
| Conley EricSVP, Orthodontics | Feb 25, 2024 | Feb 27, 2024 | F | 1,241 | $22.65 | $28,109 | 46,135 | No | Form 4 |
| Conley EricSVP, Orthodontics | Feb 25, 2024 | Feb 27, 2024 | A | 7,730 | $0.00 | $0 | 53,865 | No | Form 4 |
| Conley EricSVP, Orthodontics | Feb 25, 2024 | Feb 27, 2024 | A · derivative | 14,215 | $0.00 | $0 | 14,215 | No | Form 4 |
| Conley EricSVP, Orthodontics | Feb 25, 2024 | Feb 27, 2024 | A · derivative | 18,040 | $22.65 | $408,606 | 18,040 | No | Form 4 |
| Befidi RobertPresident, Diagnostics | Feb 25, 2024 | Feb 27, 2024 | A | 9,385 | $0.00 | $0 | 43,245 | No | Form 4 |
| Befidi RobertPresident, Diagnostics | Feb 25, 2024 | Feb 27, 2024 | A · derivative | 17,260 | $0.00 | $0 | 17,260 | No | Form 4 |
| Befidi RobertPresident, Diagnostics | Feb 25, 2024 | Feb 27, 2024 | A · derivative | 21,910 | $22.65 | $496,262 | 21,910 | No | Form 4 |
| Reis MischaSVP, Strategy & Bus. Dev. | Feb 25, 2024 | Feb 27, 2024 | F | 4,134 | $22.65 | $93,635 | 26,967 | No | Form 4 |
| Reis MischaSVP, Strategy & Bus. Dev. | Feb 25, 2024 | Feb 27, 2024 | A | 16,565 | $0.00 | $0 | 43,532 | No | Form 4 |
| Reis MischaSVP, Strategy & Bus. Dev. | Feb 25, 2024 | Feb 27, 2024 | A · derivative | 14,215 | $0.00 | $0 | 14,215 | No | Form 4 |
| Reis MischaSVP, Strategy & Bus. Dev. | Feb 25, 2024 | Feb 27, 2024 | A · derivative | 18,040 | $22.65 | $408,606 | 18,040 | No | Form 4 |
| Keller StephenPrincipal Financial Officer | Feb 25, 2024 | Feb 27, 2024 | F | 1,562 | $22.65 | $35,379 | 11,508 | No | Form 4 |
| Keller StephenPrincipal Financial Officer | Feb 25, 2024 | Feb 27, 2024 | A | 11,045 | $0.00 | $0 | 22,553 | No | Form 4 |
| Keller StephenPrincipal Financial Officer | Feb 25, 2024 | Feb 27, 2024 | A · derivative | 15,460 | $22.65 | $350,169 | 15,460 | No | Form 4 |
| Nance Mark EGeneral Counsel | Feb 25, 2024 | Feb 27, 2024 | F | 2,600 | $22.65 | $58,890 | 36,442 | No | Form 4 |
| Nance Mark EGeneral Counsel | Feb 25, 2024 | Feb 27, 2024 | A | 21,530 | $0.00 | $0 | 57,972 | No | Form 4 |
| Nance Mark EGeneral Counsel | Feb 25, 2024 | Feb 27, 2024 | A · derivative | 23,350 | $0.00 | $0 | 23,350 | No | Form 4 |
| Nance Mark EGeneral Counsel | Feb 25, 2024 | Feb 27, 2024 | A · derivative | 29,640 | $22.65 | $671,346 | 29,640 | No | Form 4 |
| Kaabi Faez CChief Accounting Officer | Feb 25, 2024 | Feb 27, 2024 | F | 1,505 | $22.65 | $34,088 | 13,715 | No | Form 4 |
| Kaabi Faez CChief Accounting Officer | Feb 25, 2024 | Feb 27, 2024 | A | 30,915 | $0.00 | $0 | 44,630 | No | Form 4 |
| Kaabi Faez CChief Accounting Officer | Feb 25, 2024 | Feb 27, 2024 | A · derivative | 20,620 | $22.65 | $467,043 | 20,620 | No | Form 4 |
| Hulit Barbara B. | Feb 15, 2024 | Feb 20, 2024 | A | 22,225 | $0.00 | $0 | 34,515 | No | Form 4 |
| Aghdaei AmirChief Executive Officer | Feb 1, 2024 | Feb 5, 2024 | A · derivative | 10,287 | $23.74 | $244,213 | 86,300 | No | Form 4 |
| Nance Mark EGeneral Counsel | Feb 1, 2024 | Feb 5, 2024 | A · derivative | 1,498 | $23.74 | $35,563 | 4,616 | No | Form 4 |
| Reis MischaSVP, Strategy & Bus. Dev. | Feb 1, 2024 | Feb 5, 2024 | A · derivative | 2,528 | $23.74 | $60,015 | 23,286 | No | Form 4 |
| Conley EricSVP, Orthodontics | Feb 1, 2024 | Feb 5, 2024 | A · derivative | 1,219 | $23.74 | $28,939 | 4,706 | No | Form 4 |
| Kaabi Faez CChief Accounting Officer | Feb 1, 2024 | Feb 5, 2024 | A · derivative | 754 | $23.74 | $17,900 | 3,165 | No | Form 4 |
| Keller StephenPrincipal Financial Officer | Feb 1, 2024 | Feb 5, 2024 | A · derivative | 548 | $23.74 | $13,010 | 1,759 | No | Form 4 |
| Conley EricSVP, Orthodontics | Nov 16, 2023 | Nov 20, 2023 | P | 2,182 | $22.89 | Purchase +$49,946 | 47,373 | No | Form 4 |
| Conley EricSVP, Orthodontics | Nov 16, 2023 | Nov 20, 2023 | P | 1 | $22.90 | Purchase +$23 | 47,374 | No | Form 4 |
| Conley EricSVP, Orthodontics | Nov 16, 2023 | Nov 20, 2023 | P | 2 | $22.90 | Purchase +$46 | 47,376 | No | Form 4 |
| Nance Mark EGeneral Counsel | Nov 8, 2023 | Nov 9, 2023 | P | 5,000 | $21.75 | Purchase +$108,750 | 39,042 | No | Form 4 |
| Keller StephenPrincipal Financial Officer | Nov 6, 2023 | Nov 7, 2023 | P | 2,000 | $21.53 | Purchase +$43,060 | 13,070 | No | Form 4 |
| Aghdaei AmirChief Executive Officer | Nov 6, 2023 | Nov 7, 2023 | P | 7,802 | $21.53 | Purchase +$167,977 | 293,164 | No | Form 4 |
| Aghdaei AmirChief Executive Officer | Nov 6, 2023 | Nov 7, 2023 | P | 600 | $21.52 | Purchase +$12,912 | 293,764 | No | Form 4 |
| Aghdaei AmirChief Executive Officer | Nov 6, 2023 | Nov 7, 2023 | P | 701 | $21.51 | Purchase +$15,079 | 294,465 | No | Form 4 |
| Aghdaei AmirChief Executive Officer | Nov 6, 2023 | Nov 7, 2023 | P | 897 | $21.50 | Purchase +$19,286 | 295,362 | No | Form 4 |